Dow Down 0.62% Nasdaq Up 0.35%

CEL-SCI Corporation (CVM)

-NYSE MKT
0.52 Up 0.02(4.00%) Feb 10, 4:00PM EST
Prev Close:0.50
Open:0.51
Bid:0.41 x 8000
Ask:0.59 x 4000
1y Target Est:3.00
Beta:-1.89955
Earnings Date:May 6 - May 10 (Est.)
Day's Range:0.49 - 0.54
52wk Range:0.36 - 1.23
Volume:976,766
Avg Vol (3m):626,714
Market Cap:67.68M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CVM

Comparison

Symbol% ChgMkt Cap
CVMUp 4.00%67.68M
CLDXDown 7.59%636.27M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):98.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-15) :N/A
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback